TQC3564 / Sino Biopharm - LARVOL DELTA

To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis (clinicaltrials.gov) - P1 | N=12 | Terminated | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | N=24 ➔ 12 | Recruiting ➔ Terminated; This study was closed per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.

Enrollment change • Trial termination • Allergic Rhinitis • Immunology • Inflammation

To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis (clinicaltrials.gov) - P1 | N=24 | Recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

New P1 trial • Allergic Rhinitis • Immunology • Inflammation